RLAY
Price
$18.87
Change
-$0.02 (-0.11%)
Updated
Sep 11 closing price
Capitalization
4.14B
60 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$24.41
Change
+$0.15 (+0.62%)
Updated
Sep 11 closing price
Capitalization
1.81B
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RLAY vs XNCR

RLAY vs XNCR Comparison Chart in %
View a ticker or compare two or three
VS
RLAY vs. XNCR commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and XNCR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($4.14B) has a higher market cap than XNCR($1.81B). RLAY YTD gains are higher at: 123.050 vs. XNCR (59.438). XNCR has higher annual earnings (EBITDA): -123.6M vs. RLAY (-308.22M). RLAY has more cash in the bank: 911M vs. XNCR (456M). RLAY has less debt than XNCR: RLAY (30.7M) vs XNCR (170M). XNCR has higher revenues than RLAY: XNCR (105M) vs RLAY (10.4M).
RLAYXNCRRLAY / XNCR
Capitalization4.14B1.81B228%
EBITDA-308.22M-123.6M249%
Gain YTD123.05059.438207%
P/E RatioN/AN/A-
Revenue10.4M105M10%
Total Cash911M456M200%
Total Debt30.7M170M18%
FUNDAMENTALS RATINGS
RLAY vs XNCR: Fundamental Ratings
RLAY
XNCR
OUTLOOK RATING
1..100
1573
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RLAY's Valuation (77) in the null industry is in the same range as XNCR (89) in the Biotechnology industry. This means that RLAY’s stock grew similarly to XNCR’s over the last 12 months.

RLAY's Profit vs Risk Rating (100) in the null industry is in the same range as XNCR (100) in the Biotechnology industry. This means that RLAY’s stock grew similarly to XNCR’s over the last 12 months.

RLAY's SMR Rating (97) in the null industry is in the same range as XNCR (97) in the Biotechnology industry. This means that RLAY’s stock grew similarly to XNCR’s over the last 12 months.

RLAY's Price Growth Rating (34) in the null industry is in the same range as XNCR (34) in the Biotechnology industry. This means that RLAY’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is in the same range as RLAY (8) in the null industry. This means that XNCR’s stock grew similarly to RLAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RLAYXNCR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (RLAY: $18.87 vs. XNCR: $24.41)
Brand notoriety: RLAY and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 205% vs. XNCR: 57%
Market capitalization -- RLAY: $4.14B vs. XNCR: $1.81B
RLAY [@Biotechnology] is valued at $4.14B. XNCR’s [@Biotechnology] market capitalization is $1.81B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green while XNCR’s FA Score has 1 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both RLAY and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 5 bearish.
  • XNCR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than XNCR.

Price Growth

RLAY (@Biotechnology) experienced а -0.89% price change this week, while XNCR (@Biotechnology) price change was -8.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

RLAY is expected to report earnings on Nov 11, 2026.

XNCR is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
RLAY
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GMEU6.870.45
+7.01%
T-Rex 2X Long GME Daily Target ETF
DDWM46.890.41
+0.87%
WisdomTree Dynamic International Eq ETF
BCLO49.720.03
+0.05%
iShares BBB-B CLO Active ETF
LGDX25.67N/A
N/A
Intech S&P Large Cap Diversified Alpha ETF
HYBB45.94-0.03
-0.05%
iShares BB Rated Corporate Bond ETF

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with KURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-0.11%
KURA - RLAY
48%
Loosely correlated
-1.56%
CGEM - RLAY
44%
Loosely correlated
-1.95%
VCYT - RLAY
44%
Loosely correlated
-2.76%
SNDX - RLAY
43%
Loosely correlated
-3.40%
XNCR - RLAY
43%
Loosely correlated
+0.62%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+0.62%
VCYT - XNCR
52%
Loosely correlated
-2.76%
KURA - XNCR
50%
Loosely correlated
-1.56%
MLTX - XNCR
49%
Loosely correlated
-5.08%
RCUS - XNCR
48%
Loosely correlated
-5.97%
VIR - XNCR
48%
Loosely correlated
+0.38%
More